期刊文献+

苯磺酸左旋氨氯地平联合缬沙坦治疗社区原发性高血压的临床疗效分析 被引量:12

Clinical effect analysis of levamlodipine besylate combined with valsartan in the treatment of essential hypertension in community
下载PDF
导出
摘要 目的:探讨苯磺酸左旋氨氯地平联合缬沙坦治疗社区原发性高血压的临床疗效。方法:收治原发性高血压患者106例,随机分为两组,每组各53例。对照组给予缬沙坦治疗,观察组给予苯磺酸左旋氨氯地平联合缬沙坦治疗,比较两组临床疗效。结果:观察组治疗总有效率显著高于对照组,治疗后血压和不良反应发生率低于对照组,差异有统计学意义(P<0.05)。结论:苯磺酸左旋氨氯地平联合缬沙坦治疗社区原发性高血压的临床疗效显著。 Objective:To investigate the clinical effect of levamlodipine besylate combined with valsartan in the treatment of essential hypertension in community.Methods:106 cases of patients with essential hypertension were divided into two groups randomly.The control group was treated with valsartan,and the observation group was treated with levamlodipine besylate combined with valsartan,the clinical effect between the two groups was compared.Results:The total effective rate of the observation group was significantly higher than that of the control group,blood pressure was lower than that of the control group, and the incidence of adverse reactions was lower than that of the control group,and the difference was statistically significant (P< 0.05).Conclusion:Levamlodipine besylate combined with valsartan was effective in treating essential hypertension in community.
作者 刘吉燕 Liu Jiyan(Pharmacy Department,the Mental Health Control Center of Licheng District in Ji'nan City 250112)
出处 《中国社区医师》 2018年第36期41-42,共2页 Chinese Community Doctors
关键词 原发性高血压 缬沙坦 苯磺酸左旋氨氯地平 临床疗效 Essential hypertension Valsartan Levamlodipine besylate Clinical effect
  • 相关文献

参考文献4

二级参考文献62

  • 1王晖,金伟.缬沙坦与苯那普利逆转左室肥厚效应及耐受性安全性的比较[J].实用医技杂志,2006,13(13):2245-2246. 被引量:2
  • 2孙宁玲,王鸿懿,诸骏仁.复方缬沙坦治疗轻中度原发性高血压患者的疗效观察[J].中华心血管病杂志,2007,35(8):715-718. 被引量:21
  • 3Mancia G, De Backer G, Dominiczak A, et al. 2007 guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hy- pertension (ESH) and of the European Society of Cardiology (ESC) [J]. J Hypertens, 2007,25 (6) :1106-1187. 被引量:1
  • 4Gerbino PP, Shoheiber O. Adherence patterns among patients treated with fixed-does combination versus separate antihypertens- ire agents [ J]. Am J Health Syst Pharm, 2007,64 (12):1379- 1283. 被引量:1
  • 5刘鸣.系统评价、Meta-分析设计与设计方法[M].北京:人民卫生出版社,2011. 被引量:1
  • 6赵文强,王连进.缬沙坦/氨氯地平在高血压治疗中的应用[J].医药前沿,2013(3):217. 被引量:1
  • 7Parati G, Faini A, Valentini M. Blood pressure variation: its measurement and significance in hypertention [ J ]. Curt Hypertens Rep, 2006,8 (9) : 199-204. 被引量:1
  • 8DeCarli C. Blood pressure control and cognitive performance: something to think about with aging[J]. JAMA, 2015, 313 (19) : 1963-1964. 被引量:1
  • 9Arosio E,De Marchi S,Prior M, et al, H aemodynamic effects of AT1 inhibition and Caz+-channel blockade in hypertensive patients during isometric stress[J]. J Hum Hypertens, 2006,20(3) : 201-205. 被引量:1
  • 10Bavanandan S, Morad Z,Ismail O, et al. A comparison of val sartan and perindopril in the treatment of essential hyperten- sion in the malaysian population[J]. Med J MaLaysia, 2005,60 (2) :158-162. 被引量:1

共引文献94

同被引文献59

引证文献12

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部